MIROMATRIX MEDICAL INC. INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 6th, 2021 • Miromatrix Medical Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionThis INVESTOR RIGHTS AGREEMENT (this "Agreement") is effective as of the 16th day of October, 2017, by and among MIROMATRIX MEDICAL INC., a Delaware corporation (the "Company"), and the persons and entities listed on the Schedule of Investors attached hereto as Exhibit A who hold Series B-2 Convertible Preferred Stock, as defined herein, (such persons and entities sometimes referred to herein, together with their transferees as permitted by Section 9 as the "Holders"). Together, the parties to this Agreement are referred to as the "Parties."
MIROMATRIX MEDICAL INC. INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 6th, 2021 • Miromatrix Medical Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionThis INVESTOR RIGHTS AGREEMENT (this “Agreement”) is effective as of the 8th day of October, 2013, by and among MIROMATRIX MEDICAL INC., a Delaware corporation (the “Company”), and the persons and entities listed on the Schedule of Investors attached hereto as Exhibit A who hold Series B Convertible Preferred Stock, as defined herein, (such persons and entities sometimes referred to herein, together with their transferees as permitted by Section 9 as the “Holders”). Together, the parties to this Agreement are referred to as the “Parties.”
MIROMATRIX MEDICAL, INC. INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • May 6th, 2021 • Miromatrix Medical Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 6th, 2021 Company Industry JurisdictionThis INVESTOR RIGHTS AGREEMENT (this “Agreement”) is effective as of the 22nd day of November, 2011, by and among MIROMATRIX, INC., a Delaware corporation (the “Company”), and the persons and entities listed on the Schedule of Investors attached hereto as Exhibit A who hold Series A Convertible Preferred Stock, as defined herein, (such persons and entities sometimes referred to herein, together with their transferees as permitted by Section 9 as the “Holders”). Together, the parties to this Agreement are referred to as the “Parties.”